2015 論文・総説（英語） Publications（International）
| 1 | Role of intrarenal (pro)renin receptor in ischemic acute kidney injury
in rats. Ono M, Sakao Y, Tsuji T, Ohashi N, Yasuda H, Nishiyama A, Fujigaki Y, Kato A. Clin Exp Nephrol. 2015 Apr;19(2):185-196. |
 |
| 2 | Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure
during the development of salt-dependent hypertension in rats. Sufiun A, Rafiq K, Fujisawa Y, Rahman A, Mori H, Nakano D, Kobori H, Ohmori K, Masaki T, Kohno M, Nishiyama A. Hypertens Res. 2015 Apr;38(4):237-243. |
|
| 3 | Renal tubule angiotensin II type 1 receptor-associated protein promotes
natriuresis and inhibits salt-sensitive blood pressure elevation. Wakui H 1, Uneda K , Tamura K , Ohsawa M , Azushima K , Kobayashi R , Ohki K , Dejima T , Kanaoka T , Tsurumi-Ikeya Y , Matsuda M , Haruhara K , Nishiyama A , Yabana M , Fujikawa T , Yamashita A , Umemura S . J Am Heart Assoc. 2015 Mar 19;4(3):e001594. |
|
| 4 | (Pro)renin receptor is crucial for Wnt/β-catenin-dependent genesis of pancreatic
ductal adenocarcinoma. Shibayama Y, Fujimori T, Nguyen G, Hirose T, Totsune K, Ichihara A, Kitada K, Nakano D, Kobori H, Kohno M, Masaki T, Suzuki Y, Yachida S, Nishiyama A. Sci Rep. 2015 Mar 9;5:8854. |
|
| 5 | Unilateral ureteral obstruction attenuates intrarenal angiotensin II generation
induced by podocyte injury. Okabe M, Miyazaki Y, Niimura F, Pastan I, Nishiyama A, Yokoo T, Ichikawa I, Matsusaka T. Am J Physiol Renal Physiol. 2015 Apr 15;308(8):F932-937. |
|
| 6 | Urinary angiotensinogen could be a prognostic marker of renoprotective
effects of alogliptin in patients with type 2 diabetes. Mizushige T, Kobori H, Nishijima Y, Yano Y, Sakata K, Hayakawa M, Nishiyama A. J Diabetes Res. 2015;2015:517472. |
|
| 7 | Chelation of dietary iron prevents iron accumulation and macrophage infiltration
in the type I diabetic kidney. Morita T, Nakano D, Kitada K, Morimoto S, Ichihara A, Hitomi H, Kobori H, Shiojima I, Nishiyama A. Eur J Pharmacol. 2015 Jun 5;756:85-91. |
|
| 8 | Association between post-transplantation immunoglobulin a deposition and
reduced allograft function. Sofue T, Inui M, Hara T, Moritoki M, Nishijima Y, Kushida Y, Nishiyama A, Kakehi Y, Kohno M. Transplant Proc. 2015 Mar;47(2):332-336. |
|
| 9 | Skeletal muscle insulin resistance in salt-sensitive hypertension: role
of angiotensin II activation of NFκB. Zhou MS, Liu C, Tian R, Nishiyama A, Raij L. Cardiovasc Diabetol. 2015 May 1;14:45. |
|
| 10 | Anti-albuminuric effects of spironolactone in patients with type 2 diabetic
nephropathy: a multicenter, randomized clinical trial. Kato S, Maruyama S, Makino H, Wada J, Ogawa D, Uzu T, Araki H, Koya D, Kanasaki K, Oiso Y, Goto M, Nishiyama A, Kobori H, Imai E, Ando M, Matsuo S. Clin Exp Nephrol. 2015 Dec;19(6):1098-106. |
|
| 11 | Inhibition of soluble epoxide hydrolase counteracts the development of
renal dysfunction and progression of congestive heart failure in Ren-2
transgenic hypertensive rats with aorto-caval fistula. ?ervenka L, Melenovsky V, Huskova Z, ?karoupkova P,?Nishiyama A, Sadowski J. Clin Exp Pharmacol Physiol. 2015 Jul;42(7):795-807. |
|
| 12 | Reduction of tubular flow rate as a mechanism of oliguria in the early
phase of endotoxemia revealed by intravital imaging. Nakano D, Doi K, Kitamura H, Kuwabara T, Mori K, Mukoyama M, Nishiyama A J Am Soc Nephrol. 2015 Dec;26(12):3035-44. |
|
| 13 | Anti-albuminuric actions of calcilytics in the remnant kidney. Takenaka T, Inoue T, Miyazaki T, Nishiyama A, Ishii N, Hayashi M, Suzuki H. Am J Physiol Renal Physiol. 2015 Aug 1;309(3):F216-226. |
|
| 14 | Role of the renal sympathetic nerve in renal glucose metabolism during
the development of type 2 diabetes in rats. Rafiq K, Fujisawa Y, Sherajee SJ, Rahman A, Sufiun A, Kobori H, Koepsell H, Mogi M, Horiuchi M, Nishiyama A. Diabetologia. 2015 Dec;58(12):2885-2898. |
|
| 15 | Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive
and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt
hypertensive rats. Alanova P, Huskova Z, Kopkan L, Sporkova A, Jichova ?, Necka? J, Imig JD, Klevstig M, Kola? F, Rami Reddy N, Falck JR, Sadowski J, Nishiyama A, Kramer HJ, Melenovsky V, ?ervenkova L, Kujal P, Vernerova Z, ?ervenka L. Vascul Pharmacol. 2015 Oct;73:45-56. |
|
| 16 | Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac
oxidative stress in angiotensin II-infused rats. Minas JN, Thorwald M, Conte D, Vazquez-Medina J-P, Nishiyama A, Ortiz RM Clin Exp Pharmacol Physiol. 2015 Nov;42(11):1178-1188. |
|
| 17 | Depressor Effect of Chymase Inhibitor in Mice with High Salt-Induced Moderate
Hypertension. Devarajan S, Yahiro E, Uehara Y, Habe S,?Nishiyama A, Miura S, Saku K, Urata H. Am J Physiol Heart Circ Physiol. 2015 Dec 1;309(11):H1987-1996. |
|
| 18 | Enhanced interference-pattern visibility using multislit optical superposition
method for imaging-type two-dimensional fourier spectroscopy. Qi W, Suzuki Y, Sato S, Fujiwara M, Kawashima N, Suzuki S, Abeygunawardhana P, Wada K, Nishiyama A, Ishimaru I. Appl Opt. 2015 Jul 10;54(20):6254-9 |
|
| 19 | Proposal of AAA-battery-size one-shot ATR Fourier spectroscopic imager for on-site analysis - Simultaneous measurement of multi-components with high accuracy - Satsuki Hosono, Wei Qi, Shun Sato, Yo Suzuki, Masaru Fujiwara, Hiroyuki Hiramatsu, Satoru Suzuki, P. K. W. Abeygunawardhanaa Kenji Wada, Akira Nishiyama, Ichiro Ishimaru. OPTICS AND BIOPHOTONICS IN LOW-RESOURCE SETTINGS 9314. |
|
| 20 | In-situ monitoring of blood glucose level for dialysis machine by AAA-battery-size ATR Fourier spectroscopy. Satsuki Hosono, Shun Sato, Akane Ishida, Yo Suzuki, Daichi Inohara, Kosuke Nogo, Pradeep K. W. Abeygunawardhana, Satoru Suzuki, Akira Nishiyama, Kenji Wada, Ichiro Ishimaru. CLINICAL AND BIOMEDICAL SPECTROSCOPY AND IMAGING IV 9537 |
|